11.12.2022, 2503 Zeichen

Valneva: Valneva SE, a specialty vaccine company, today reported positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate, VLA1553. Following positive immunogenicity and safety data for Phase 3 study VLA1553-301 in March 2022. Valneva set up a dedicated antibody persistence trial (VLA1553-303) to monitor a subset of participants for a period of at least five years and confirm the anticipated long-term durability of the antibody response after a single vaccination. No safety concerns were identified for the duration of the follow-up study, confirming the safety profile observed in previous studies. Juan Carlos Jaramillo, Chief Medical Officer of Valneva, said, “We are excited about these twelve-month data which are in line with what we saw from our previous read out at month 6, and strengthen the possibilities of inducing a long-lasting antibody response with our chikungunya vaccine candidate. We are looking forward to completing the BLA rolling submission to the FDA and potentially to changing people’s lives. If our investigational vaccine is approved, we are confident that it can help address this major, growing and unmet public health threat.”
Valneva: weekly performance: -0.42%

Erste Group: Erste Group’s initial public offering (IPO) was realized through a listing on the Vienna Stock Exchange 25 years ago, on 4 December 1997. The funds raised by going public in 1997 and through subsequent offerings helped finance Erste Group’s growth in Central and Eastern Europe, as well as investments into market-leading technology and digital innovations. With a volume corresponding to around 510 mn euros, Erste’s 1997 IPO marked the largest share issue in Austrian stock market history up to that time. CEO Willi Cernko: “Erste’s IPO 25 years ago laid the foundation for a success story. Erste took the right step and raised capital through the stock exchange for major acquisitions in the 2000’s. Thanks to this expansion, Erste Group has advanced to become the leading banking group in the eastern part of the EU."
Erste Group: weekly performance: -1.17%

Vienna Stock Exchange: The Vienna Stock Exchange recorded an equity turnover of Euro 67.98 bn year-to-date and, with an increase of 0.4 % (Jan-Nov 2021: Euro 67.69 billion), is at the previous year's level. In the month of November 2022, the equity turnover amounted to Euro 5.55 bn.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (05/12/2022)

Christian Drastil: Wiener Börse Plausch

SportWoche ÖTV-Spitzentennis Podcast: Sebastian Ofner, Joel Schwärzler und Sebastian Sorger liefern den erwünschten Aufschwung

Bildnachweis

Aktien auf dem Radar:Bawag, FACC, RHI Magnesita, Kapsch TrafficCom, Austriacard Holdings AG, Polytec Group, Rosgix, AT&S, ATX, ATX TR, voestalpine, Porr, ATX NTR, Erste Group, Amag, DO&CO, EuroTeleSites AG, Hutter & Schrantz Stahlbau, Lenzing, OMV, Bajaj Mobility AG, RBI, Rosenbauer, Verbund, Wienerberger, Wolford, BKS Bank Stamm, Oberbank AG Stamm, UBM, Marinomed Biotech, CA Immo.

---